Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Anesthesiology. 2018 Feb;128(2):328–337. doi: 10.1097/ALN.0000000000001981

Table 3.

Cost-Effectiveness Rankings for base case.

Strategy Cost Incremental Cost Effectiveness Incremental Effectiveness ICER
No IOCS $11,431.74 23.97
IOCS High Risk Only $11,432.40 $0.67 23.97 0.000019 $34,881.69
IOCS All $11,509.63 $77.23 23.97 0.000186 $415,488.39

ICER, incremental cost effectiveness ratio

IOCS, intraoperative cell salvage